Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Duration of adjuvant treatment: Is “as long as possible” the key?

CONTRA: Limited duration

Date

27 Mar 2025

Session

Duration of adjuvant treatment: Is “as long as possible” the key?

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Rafal Dziadziuszko

Authors

R. Dziadziuszko

Author affiliations

Medical University of Gdansk, Gdansk/PL

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

27 Mar 2025

Introduction and first vote

Presenter: Heather Wakelee

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast

27 Mar 2025

PRO: As long as possible

Presenter: Hye Ryun Kim

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast

27 Mar 2025

Second vote and conclusions/discussion

Presenter: Heather Wakelee

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast